Geode Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Buy
1,254,114
+10,147
+0.8% +$192K ﹤0.01% 1957
2025
Q4
$23.4M Sell
1,243,967
-53,458
-4% -$896K ﹤0.01% 1916
2025
Q3
$18.9M Sell
1,297,425
-26,072
-2% -$372K ﹤0.01% 2029
2025
Q2
$25.9M Buy
1,323,497
+43,074
+3% +$765K ﹤0.01% 1829
2025
Q1
$22.7M Buy
1,280,423
+46,160
+4% +$994K ﹤0.01% 1837
2024
Q4
$26.4M Buy
1,234,263
+6,539
+0.5% +$159K ﹤0.01% 1810
2024
Q3
$38.3M Buy
1,227,724
+32,141
+3% +$800K ﹤0.01% 1606
2024
Q2
$18.6M Buy
1,195,583
+527
+0% +$6.37K ﹤0.01% 1964
2024
Q1
$12.7M Buy
1,195,056
+36,100
+3% +$361K ﹤0.01% 2185
2023
Q4
$13.9M Buy
1,158,956
+50,141
+5% +$411K ﹤0.01% 2139
2023
Q3
$7.76M Buy
1,108,815
+25,806
+2% +$238K ﹤0.01% 2410
2023
Q2
$9.21M Buy
1,083,009
+66,479
+7% +$554K ﹤0.01% 2332
2023
Q1
$9.29M Buy
1,016,530
+34,511
+4% +$441K ﹤0.01% 2294
2022
Q4
$11.2M Buy
982,019
+45,232
+5% +$670K ﹤0.01% 2196
2022
Q3
$15.9M Buy
936,787
+13,595
+1% +$292K ﹤0.01% 1904
2022
Q2
$19.8M Buy
923,192
+2,867
+0.3% +$79.5K ﹤0.01% 1777
2022
Q1
$34M Sell
920,325
-9,548
-1% -$372K ﹤0.01% 1523
2021
Q4
$42.3M Buy
929,873
+13,847
+2% +$723K 0.01% 1433
2021
Q3
$58M Buy
916,026
+20,618
+2% +$1.57M 0.01% 1150
2021
Q2
$81.9M Buy
895,408
+28,661
+3% +$2.28M 0.01% 926
2021
Q1
$59M Buy
866,747
+103,319
+14% +$8.02M 0.01% 1098
2020
Q4
$55.3M Buy
763,428
+62,174
+9% +$3.6M 0.01% 1030
2020
Q3
$26.6M Buy
701,254
+91,548
+15% +$3.09M 0.01% 1315
2020
Q2
$21.6M Buy
609,706
+27,997
+5% +$797K ﹤0.01% 1461
2020
Q1
$12.7M Buy
581,709
+31,500
+6% +$706K ﹤0.01% 1587
2019
Q4
$11.9M Sell
550,209
-10,798
-2% -$248K ﹤0.01% 1892
2019
Q3
$12.7M Buy
561,007
+12,542
+2% +$347K ﹤0.01% 1769
2019
Q2
$19.7M Buy
548,465
+68,094
+14% +$2.18M ﹤0.01% 1489
2019
Q1
$15.1M Buy
480,371
+80,703
+20% +$2.35M ﹤0.01% 1610
2018
Q4
$10M Buy
399,668
+42,944
+12% +$1.1M ﹤0.01% 1787
2018
Q3
$10.3M Buy
356,724
+46,676
+15% +$873K ﹤0.01% 1895
2018
Q2
$3.79M Buy
310,048
+158,338
+104% +$1.82M ﹤0.01% 2495
2018
Q1
$1.21M Buy
151,710
+21,684
+17% +$134K ﹤0.01% 3035
2017
Q4
$954K Buy
130,026
+86,887
+201% +$542K ﹤0.01% 3123
2017
Q3
$159K Hold
43,139
﹤0.01% 3720
2017
Q2
$47K Hold
43,139
﹤0.01% 3968
2017
Q1
$60K Hold
43,139
﹤0.01% 3916
2016
Q4
$116K Hold
43,139
﹤0.01% 3759
2016
Q3
$153K Buy
43,139
+28,027
+185% +$129K ﹤0.01% 3679
2016
Q2
$65K Hold
15,112
﹤0.01% 3884
2016
Q1
$74 Hold
15,112
﹤0.01% 3899
2015
Q4
$96K Hold
15,112
﹤0.01% 3894
2015
Q3
$63K Buy
+15,112
New +$99.9K ﹤0.01% 3979

Other funds holding CDNA

Geode Capital Management's CDNA Position: Q1 2026 in Review

Geode Capital Management increased its CareDx (CDNA) stake by 0.82% in Q1 2026, buying an estimated $192K and bringing the position to 1,254,114 shares worth $21.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

Geode Capital Management first reported a position in CDNA in Q3 2015 and has held it in 43 quarters since. The position peaked at $81.9M in Q2 2021. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.

  • Geode Capital Management held 1,254,114 shares of CareDx worth $21.8M as of Q1 2026.
  • Geode Capital Management bought 10,147 CareDx shares in Q1 2026, an estimated $192K.
  • CareDx made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #1957 holding.
  • Geode Capital Management first reported a position in CareDx in Q3 2015 and has held it in 43 quarters since.
  • Geode Capital Management's CareDx position peaked at $81.9M in Q2 2021.
  • 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.